Pentair Affirms FY2026 Adj EPS Guidance of $4.60-$4.80 vs $4.88 Est; Affirms FY2026 Sales Guidance of $3.884B-$4.009B vs $4.012B Est

Kaplan Fox Reminds Investors of a Securities Class Action Against UWM Holdings Corporation (NYSE: UWMC) – Deadline is October 13, 2026

Kaplan Fox has filed securities class action lawsuits against UWM Holdings Corporation, Taboola.com Ltd., and Pentair plc on behalf of investors who suffered losses during specified periods. The primary case against UWM Holdings alleges the company failed to disclose that it had deviated from its traditional strategy by over-hedging mortgage servicing rights in anticipation of the Two Harbors transaction, resulting in a $603.2 million derivative loss and a 34.78% stock price decline on August 6, 2026.

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role

Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against Capricor Therapeutics, Pentair plc, and Bloom Energy Corporation on behalf of investors who suffered losses. The primary case involves Capricor, where the FDA released briefing documents revealing that the company made undisclosed changes to its statistical analysis plan for a drug application, resulting in a 64% stock price drop on July 27, 2026.

TD Cowen Maintains Sell on Pentair, Lowers Price Target to $65

Baird Maintains Outperform on Pentair, Lowers Price Target to $80